Zobrazeno 1 - 10
of 186
pro vyhledávání: '"J L, Selam"'
Autor:
Jennie G. Jacobson, Junxiang Luo, Satish K. Garg, Qianyi Zhang, Nanette C. Schloot, A. Bhargava, Byron J. Hoogwerf, J.-L. Selam
Publikováno v:
Diabetes, Obesity and Metabolism. 18:43-49
Aims To compare 24-hour fixed-time basal insulin peglispro (BIL) dosing with 8- to 40-hour variable-time BIL dosing for glycaemic control and safety in patients with type 1 diabetes. Primary outcome was non-inferiority of BIL variable-time dosing com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daa1984dbae4aa24e431d8dff5c6debc
https://doi.org/10.1111/dom.12740
https://doi.org/10.1111/dom.12740
Autor:
Jennie G. Jacobson, Junxiang Luo, Tibor Ivanyi, Mark L. Hartman, Z. Kerényi, David Russell-Jones, Scott J. Jacober, Juliana M. Bue-Valleskey, J.‐L. Selam, T. S. Bailey, Melanie J. Davies
Publikováno v:
Diabetes, Obesity & Metabolism
Aims To compare, in a double‐blind, randomized, multi‐national study, 52‐ or 78‐week treatment with basal insulin peglispro or insulin glargine, added to pre‐study oral antihyperglycaemic medications, in insulin‐naïve adults with type 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::476ee252adf491bd3d21abafe854b363
https://doi.org/10.1111/dom.12712
https://doi.org/10.1111/dom.12712
Publikováno v:
Nitric Oxide. 13:88-92
Genetic factors could be implicated in the pathogenesis of severe diabetic retinopathy (DR). Recently, we reported a strong association between the eNOS4b/a endothelial nitric oxide synthase (eNOS) polymorphism and severe DR. To examine whether T-786
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::585e1bc53103500229030ab6dc84d8f7
https://doi.org/10.1016/j.niox.2005.04.004
https://doi.org/10.1016/j.niox.2005.04.004
Autor:
J.-L. Selam
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 109:S333-S340
External insulin infusion (CSII) pumps have regained interest since DCCT, the number of patients approaching 100,000 in the USA. Only 2 manufacturers (Minimed, Disetronic) and 2 insulins (lispro, insuman) are sharing the market. The major advantages
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df5f8ddaeaf1e07db29302583c67043d
https://doi.org/10.1055/s-2001-18592
https://doi.org/10.1055/s-2001-18592
Publikováno v:
Diabetic Medicine. 18:584-588
BACKGROUND AND AIMS Secondary failure to oral hypoglycaemic agents, a common evolution of long-standing Type 2 diabetes, is usually assessed by non-standardized indices requiring fine clinical assessment, including hyperglycaemia resistant to maximum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72af3ebf678ad97ba9b4b61e1f7083d9
https://doi.org/10.1046/j.1464-5491.2001.00534.x
https://doi.org/10.1046/j.1464-5491.2001.00534.x
Autor:
J L Selam
Publikováno v:
ASAIO Journal. 43:137-142
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23eb92ad364e93fe49ae230d48fe7b64
https://doi.org/10.1097/00002480-199743030-00004
https://doi.org/10.1097/00002480-199743030-00004
Publikováno v:
Diabetic Medicine. 12:1102-1109
Intraperitoneal (IP) insulin infusion with programmable implantable pumps is associated with a reduction in hypoglycaemic events when compared to intensive diabetes management with subcutaneous insulin in patients with Type 1 diabetes mellitus. The m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc4c0311c93f7668eb1cbfe702ebe856
https://doi.org/10.1111/j.1464-5491.1995.tb00428.x
https://doi.org/10.1111/j.1464-5491.1995.tb00428.x
Autor:
E. Chan, Nathan D. Wong, M. Nagy, Mohamed Iravani, J.-L. Selam, Charles Ma, Kenneth Waxman, D. S. Turner, Olsen Cl
Publikováno v:
Diabetes Care. 17:169-176
OBJECTIVE To determine whether insulin antibodies are generated in diabetic patients after short- and long-term intraperitoneal insulin use and, if so, whether they are of potential clinical interest. Insulin antibodies commonly develop in diabetic p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e42759be4c603342b5ac77992decfc02
https://doi.org/10.2337/diacare.17.3.169
https://doi.org/10.2337/diacare.17.3.169
Autor:
D. Turner, Liu G, J.-L. Selam, Kenneth Waxman, Khourdadjian K, Olsen Cl, Charles Ma, Iravani M, Nguyen S
Publikováno v:
The International Journal of Artificial Organs. 16:847-854
Objectives Since only short-term studies of continuous intraperitoneal insulin infusion (CIPII) therapy using implantable programmable insulin delivery systems have been performed to show this method of diabetes therapy to be safe and efficacious, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61a653593e2efb43849752aebdd5276c
https://doi.org/10.1177/039139889301601211
https://doi.org/10.1177/039139889301601211